Publication | Closed Access

Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial

HypertensionBlood PressureCardiovascular DiseaseAntihypertensive AgentsAntihypertensive TherapyPharmacologyCardiovascular PharmacologyPharmacotherapyMedicineDual CombinationsInternational Clinical Trial